1. TMIC-01. THE DYSTROGLYCAN RECEPTOR MAINTAINS GLIOMA STEM CELLS IN THE VASCULAR NICHE. (11th November 2019) Authors: Day, Bryan; Lathia, Justin; Bruce, Zara; Ensbey, Kathleen; Chieh Lim, Yi; Jamieson, Paul; D'Souza, Rochelle; Akgul, Seckin; Offenhauser, Carolin; Baumgartner, Ulrich; Smith, Fiona; Li, Yuchen; Jurd, Courtney; Stringer, Brett; Robertson, Thomas; Jeffree, Rosalind; Johns, Terrance; Bhat, Krishna; R... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MBRS-09. EphA3 A NOVEL TUMOUR SPECIFIC THERAPEUTIC TARGET FOR MEDULLOBLASTOMA. Issue 2 (22nd June 2018) Authors: Offenhauser, Carolin; Carrington, Benjamin; Thurecht, Kris; Ensbey, Kathleen; Bruce, Zara; Jamieson, Paul; Lim, Yi Chieh; Akgul, Seckin; Li, Michelle; Stringer, Brett; Puttick, Simon; Fuchs, Adrian; Picard, Daniel; Ingram, Wendy; Hallahan, Andrew; Moore, Andrew; Johns, Terrance; Gottardo, Nichola... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EAPH-16. DISCOVERY OF CT-179: A SMALL MOLECULE INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOR IN PEDIATRIC BRAIN CANCER. Issue 2 (22nd June 2018) Authors: Johns, Terrance; Greenall, Sameer; Chen, Charlotte; Day, Bryan Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MBRS-09. EphA3 A NOVEL TUMOUR SPECIFIC THERAPEUTIC TARGET FOR MEDULLOBLASTOMA. Issue 2 (22nd June 2018) Authors: Offenhauser, Carolin; Carrington, Benjamin; Thurecht, Kris; Ensbey, Kathleen; Bruce, Zara; Jamieson, Paul; Lim, Yi Chieh; Akgul, Seckin; Li, Michelle; Stringer, Brett; Puttick, Simon; Fuchs, Adrian; Picard, Daniel; Ingram, Wendy; Hallahan, Andrew; Moore, Andrew; Johns, Terrance; Gottardo, Nichola... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EAPH-16. DISCOVERY OF CT-179: A SMALL MOLECULE INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOR IN PEDIATRIC BRAIN CANCER. Issue 2 (22nd June 2018) Authors: Johns, Terrance; Greenall, Sameer; Chen, Charlotte; Day, Bryan Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ATIM-23. PRELIMINARY FINDINGS OF A PHASE I SAFETY AND BIOIMAGING TRIAL OF KB004 (IFABOTUZUMAB) IN PATIENTS WITH GLIOBLASTOMA. (11th November 2019) Authors: Gan, Hui; Cher, Lawrence; Inglis, Po; Lwin, Zarnie; Lau, Eddie; Ackermann, Uwe; Coombs, Nicole; Remen, Kirsten; Guo, Nancy; Ting Lee, Sze; Gong, Sylvia; Palmer, Jodie; Pathmaraj, Kunthi; O'Keefe, Graeme; Scott, Fiona; Day, Bryan; Boyd, Andrew; Thomas, Paul; Durrant, Cameron; Scott, Andrew Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. INNV-08. LOW AND INTERMEDIATE GRADE GLIOMA UMBRELLA STUDY OF MOLECULAR GUIDED THERAPIES (LUMOS) STUDY. (12th November 2021) Authors: Kong, Benjamin; Sim, Hao-Wen; Amanuel, Benhur; Day, Bryan; Buckland, Michael; Verhaak, Roel; Yip, Sonia; Johns, Terrance; Lwin, Zarnie; Rosenthal, Mark; Nowak, Anna K; Barnes, Elizabeth H; Scott, Andrew M; Parkinson, Jonathon; Jeffree, Rosalind; Lourenco, Richard De Abreu; Lau, Peter; Whittle, Ja... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Primitive or empowered: representations of Native Americans and COVID-19 in news media. Issue 1 (1st January 2023) Authors: Davidson, Theresa; Miller, Niya Pickett; Day, Bryan Journal: Communication quarterly Issue: Volume 71:Issue 1(2023) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EXTH-12. PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA. (14th November 2022) Authors: Jackson, Evangeline; Duchatel, Ryan; Persson, Mika; Mannan, Abdul; Yadavilli, Sridevi; Parackal, Sarah; Game, Shaye; Chong, Wai Chin; Jayasekara, Samantha; Le Grand, Marion; Kearney, Padraic; Douglas, Alicia; Findlay, Izac; Staudt, Dilana; Germon, Zacary; Skerrett-Byrne, David; Nixon, Brett; Smit... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse midline glioma (NCT05009992). (3rd June 2022) Authors: Dun, Matthew D; Jackson, Evangeline R; Duchatel, Ryan J; Persson, Mika L; Mannan, Abdul; Yadavilli, Sridevi; Parackal, Sarah; Game, Shaye; Chong, Wai Chin; Jayasekara, Samantha; Le Grand, Marion; Kearney, Padraic S; Douglas, Alicia M; Findlay, Izac J; Staudt, Dilana; Germon, Zacary P; Skerrett-By... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗